Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2022.10.008Source: DataRank Database

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes is a research paper published in Journal of the American College of Cardiology (2022). On theSindex it has a DataRank of 0. It has been cited 159 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access159 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 20.99)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Antoine Bejjani ORCID,Gregory Piazza ORCID,David Jiménez ORCID,Manuel Monréal ORCID,Saurav Chatterjee ORCID

Live enrichment

PubMed:36328154 PMC:PMC9812926 OpenAlex:https://openalex.org/W4307684607

Intramural NIH HHS

Grant: ZIA HL006263

NCATS NIH HHS

Grant: UL1 TR001863

Intramural NIH HHS

Grant: ZIA HL006262

Intramural NIH HHS

Grant: ZIA HL006267

FWCI

20.99

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://repository.ubn.ru.nl//bitstream/handle/2066/290155/290155.pdf

publisherhttps://api.elsevier.com/content/article/PII:S073510972207098X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S073510972207098X?httpAccept=text/plain

repositoryhttps://hdl.handle.net/2066/290155

Fields of Study

Systemic Lupus Erythematosus ResearchHeparin-Induced Thrombocytopenia and ThrombosisCerebral Venous Sinus ThrombosisHumansAdministration, OralAnticoagulantsAntiphospholipid SyndromeFibrinolytic AgentsHemorrhageRandomized Controlled Trials as TopicThrombosisVenous ThromboembolismVitamin K

MeSH Terms

Administration, OralAnticoagulantsFibrinolytic AgentsHemorrhageHumansThrombosisVitamin KRandomized Controlled Trials as TopicAntiphospholipid SyndromeVenous Thromboembolism

Keywords

MedicineInternal medicineRandomized controlled trialOdds ratioAntiphospholipid syndromeThrombosisWarfarinStroke (engine)GastroenterologySurgeryAtrial fibrillationMortalityBleedingStrokeVenous ThromboembolismArterial Thrombosis

Sustainable Development Goals

SDG 0: Good health and well-being